Max Healthcare Institute announced Q1FY24 results: Gross revenue stood at Rs 1,719 crore for Q1FY24, +17% growth YoY & +5% growth QoQ Network operating EBITDA was Rs 436 crore, with growth of +18% YoY and flat QoQ, despite Q1 traditionally being a weak quarter compared to Q4 Operating margin stood at 26.8% versus 26.5% in Q1FY23 and 28.2% in Q4FY23 EBITDA per bed improved to Rs 70.4 lakh in Q1FY24, from Rs 62.0 lakh in Q1FY23 and Rs 70.3 lakh in Q4FY23 PAT stood at Rs 291 crore in Q1FY24 versus Rs 229 crore in Q1FY23 and Rs 320 crore in Q4FY23 Cash from operations was Rs 261 crore in Q1FY24, of this Rs 38 crore was spent towards ongoing capacity expansion projects; net cash as on June 30, 2023, stood at Rs 957 crore Bed occupancy in Q1FY24 stood at 74% and Occupied Bed Days (OBD) grew by +3% YoY. Network bed capacity stood at 3,550 Beds after the addition of 30 new beds at Max Shalimar Bagh, over and above the 92-bed Oncology Block commissioned in Mar 2023 ARPOB5 improved to Rs 74.8k in Q1FY24 vs. Rs 66.0k in Q1FY23 and 70.7K in Q4FY23 Free treatment provided to 37,516 patients in OPD and 1,260 patients in IPD from the economically weaker sections Commenting on Q1FY24 results, Abhay Soi, Chairman and Managing Director, Max Healthcare Institute, said, “I am happy that despite the traditionally weak Q1, we could deliver our highest ever quarterly revenue and improve profitability at bed level. While our installed capacity increased by 4% on a YoY basis, we maintained our occupancy levels with higher occupied beds across the Network. In the past year, we have significantly strengthened our projects and digital teams to reinforce our thrust in both these areas, which is intrinsic to our growth going forward. I am proud of the success and positive feedback received for our Max MyHealth app which has now been fully rolled out.” Result PDF